Global /China /Healthcare /Drug Manufacturers - General /600572

Zhejiang CONBA Pharmaceutical Co.,Ltd.

600572

• SSE: 600572 • Delayed

4.48CNY 0.2%

0.6620 USD

As of 17 June 2026, Zhejiang CONBA Pharmaceutical Co.,Ltd. has a market cap of $1.67B USD, ranking #7921 globally and #2007 in China. It ranks #664 in the Healthcare sector, and #255 in the Drug Manufacturers - General industry.

Global Rank

7921

Country Rank

2007

Sector Rank

664

Industry Rank

255

Key Stats

Market Cap

$1.67BUSD

11.34B CNY

Enterprise Value

$1.49BUSD

10.07B CNY

Revenue (TTM)

$988.59MUSD

6.69B CNY

EBITDA (TTM)

$137.86MUSD

932.98M CNY

Net Income (TTM)

$71.39MUSD

483.42M CNY

EBITDA Margin

14%

Profit Margin

7.2%

PE Ratio

23.5

PS Ratio

1.7

PB Ratio

1.5

EV/EBITDA

11.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Guoliang Luo open_in_new

Employees

8,411

Founded

1969

Website

conbapharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.2%	-2.8%	3%	-2.4%	0.4%	0.2%	-2%	-35%	5.9%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600572 浙江康恩贝制药股份有限公司 Class A ISIN: CNE000001H86 Shares Out.: Shares Outstanding: 2.537B¹ Shares Float: 1.604B² TV: TradingView: SSE: 600572 SA: Stock Analysis: SHA: 600572 YF: Yahoo Finance: 600572.SS GF: Google Finance: SHA: 600572 BA: Barron's: 600572 MS: Morningstar: XSHG: 600572	4.48 CNY	TV: TradingView: SSE: 600572 SA: Stock Analysis: SHA: 600572 YF: Yahoo Finance: 600572.SS GF: Google Finance: SHA: 600572 BA: Barron's: 600572 MS: Morningstar: XSHG: 600572

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang CONBA Pharmaceutical Co.,Ltd.

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it offers prescription pieces, formula granules, plant extracts, and other products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 3K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 3K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 1K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 887%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 856%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 45K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 33K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 21K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 19K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 17K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 16K%	20.5	Switzerland

chevron_leftBack